President and CEO of Anthera Pharmaceuticals Inc. (ANTH, Financial) Paul F Truex sells 15,000 shares of ANTH on 12/15/2011 at an average price of $6.34 a share.
Anthera Pharmaceuticals Inc. has a market cap of $253.1 million; its shares were traded at around $6.36 .
For the complete insider trading history of ANTH, click here.
Anthera Pharmaceuticals Inc. has a market cap of $253.1 million; its shares were traded at around $6.36 .
CEO Recent Trades:
- President and CEO Paul F Truex sold 30,000 shares of ANTH stock on 11/15/2011 at the average price of 6.96. Paul F Truex owns at least 697,637 shares after this. The price of the stock has decreased by 8.62% since.
- President and CEO Paul F Truex sold 23,235 shares of ANTH stock on 10/21/2011 at the average price of 6.25. Paul F Truex owns at least 727,637 shares after this. The price of the stock has increased by 1.76% since.
- President and CEO Paul F Truex sold 6,745 shares of ANTH stock on 10/18/2011 at the average price of 6.25. Paul F Truex owns at least 750,872 shares after this. The price of the stock has increased by 1.76% since.
- President and CEO Paul F Truex sold 15,000 shares of ANTH stock on 07/15/2011 at the average price of 7.95. Paul F Truex owns at least 707,637 shares after this. The price of the stock has decreased by 20% since.
CFO Recent Trades:
- CFO & CBO Christopher P. Lowe sold 5,000 shares of ANTH stock on 08/02/2011 at the average price of 7.31. Christopher P. Lowe owns at least 55,788 shares after this. The price of the stock has decreased by 13% since.
Directors and Officers Recent Trades:
- Director Advisors Llc Orbimed sold 56,200 shares of ANTH stock on 12/13/2011 at the average price of 6.68. Advisors Llc Orbimed owns at least 2,831,800 shares after this. The price of the stock has decreased by 4.79% since.
- Director, 10% Owner Advisors Llc Orbimed sold 52,000 shares of ANTH stock on 11/18/2011 at the average price of 6.76. Advisors Llc Orbimed owns at least 2,888,000 shares after this. The price of the stock has decreased by 5.92% since.
- Director, 10% Owner Advisors Llc Orbimed sold 60,000 shares of ANTH stock on 11/15/2011 at the average price of 6.95. Advisors Llc Orbimed owns at least 2,940,000 shares after this. The price of the stock has decreased by 8.49% since.
- Chief Medical Officer Colin Hislop sold 15,000 shares of ANTH stock on 11/08/2011 at the average price of 6.74. Colin Hislop owns at least 73,150 shares after this. The price of the stock has decreased by 5.64% since.
For the complete insider trading history of ANTH, click here.
